Sonia Moniz
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' Disease.
Journal: Antimicrobial agents and chemotherapy
Published: October 04, 2021
The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani.
Journal: ACS infectious diseases
Published: January 23, 2020
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2019
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.
Journal: ACS infectious diseases
Published: November 02, 2018
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals.
Journal: Antimicrobial agents and chemotherapy
Published: February 05, 2018
Cezanne regulates E2F1-dependent HIF2α expression.
Journal: Journal of cell science
Published: January 13, 2015
PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 07, 2015
Cezanne (OTUD7B) regulates HIF-1α homeostasis in a proteasome-independent manner.
Journal: EMBO reports
Published: October 31, 2014
Grow₂: the HIF system, energy homeostasis and the cell cycle.
Journal: Histology and histopathology
Published: January 11, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026